CONTEXTVISION AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.96 NOK | -0.67% |
|
+1.71% | -22.60% |
| Apr. 03 | ContextVision Announces New Image Quality Advancements in X-Ray | CI |
| Feb. 16 | Transcript : ContextVision AB, Q4 2023 Earnings Call, Feb 16, 2024 |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 135M 12.35M | Sales 2025 * | 141M 12.91M | Capitalization | 461M 42.25M |
|---|---|---|---|---|---|
| Net income 2024 * | 18M 1.65M | Net income 2025 * | 20M 1.83M | EV / Sales 2024 * | 2.88 x |
| Net cash position 2024 * | 73.14M 6.7M | Net cash position 2025 * | 79.57M 7.29M | EV / Sales 2025 * | 2.71 x |
| P/E ratio 2024 * |
25.8
x | P/E ratio 2025 * |
22.7
x | Employees | 40 |
| Yield 2024 * |
3.37% | Yield 2025 * |
4.21% | Free-Float | 34.24% |
More Fundamentals
* Assessed data
More news
Latest transcript on ContextVision AB
More press releases
| 1 day | -0.67% | ||
| 1 week | +1.71% | ||
| Current month | +1.71% | ||
| 1 month | -10.78% | ||
| 3 months | -33.92% | ||
| 6 months | -18.36% | ||
| Current year | -22.60% |
1 week
5.70
6.18
1 month
5.706.98
Current year
5.709.20
1 year
5.709.20
3 years
5.7027.10
5 years
5.0530.90
10 years
1.4430.90
| Managers | Title | Age | Since |
|---|---|---|---|
Gerald Pötzsch
CEO | Chief Executive Officer | 52 | 22-07-31 |
| Director of Finance/CFO | - | 23-08-27 | |
Gunnar Läthén
CTO | Chief Tech/Sci/R&D Officer | - | 12-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Martin Hedlund
FOU | Founder | 72 | 82-12-31 |
Lars Olof Sandèn
CHM | Chairman | 62 | 21-05-04 |
| Founder | 70 | 82-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-07 | 5.96 | -0.67% | 45,626 |
| 24-05-06 | 6 | 0.00% | 89,949 |
| 24-05-03 | 6 | +1.69% | 46,791 |
| 24-05-02 | 5.9 | +0.68% | 164,586 |
| 24-04-30 | 5.86 | -2.01% | 74,922 |
Real-time Oslo Bors, May 07, 2024 at 10:45 am EDT
More quotes
ContextVision AB is a Sweden-based medical technology software company specialized in image analysis and artificial intelligence. The Company is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The Company develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVisionâs cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The Company operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.
Calendar
02:00am
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
5.96
NOK
Average target price
6.5
NOK
Spread / Average Target
+9.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.60% | 42.85M | |
| +6.64% | 32.83B | |
| +18.02% | 7.73B | |
| +23.82% | 3.96B | |
| -16.41% | 3.12B | |
| -19.48% | 1.38B | |
| -30.77% | 1.2B | |
| +8.47% | 963M | |
| -32.21% | 934M | |
| -28.36% | 829M |
- Stock Market
- Equities
- CONTX Stock